Home

pentru mine Figura Andes cabinet medical biosim Cooperare sunt bolnav Dreptunghi

Cum să ajungi la Biosim în Centru folosind Autobuz?
Cum să ajungi la Biosim în Centru folosind Autobuz?

Română
Română

Multiple infliximab biosimilar switches appear to be safe and effective in  a real‐world inflammatory bowel disease cohort - Gros - 2023 - United  European Gastroenterology Journal - Wiley Online Library
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort - Gros - 2023 - United European Gastroenterology Journal - Wiley Online Library

Amgen falls short in Epogen patent appeal but Pfizer stumble delays  competition | Fierce Pharma
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition | Fierce Pharma

MSD launches first Herceptin biosimilar in UK
MSD launches first Herceptin biosimilar in UK

ADVANZ PHARMA enters into an exclusive agreement with Alvotech to  commercialise a proposed biosimilar to Xolair® (omalizumab) | ADVANZ PHARMA
ADVANZ PHARMA enters into an exclusive agreement with Alvotech to commercialise a proposed biosimilar to Xolair® (omalizumab) | ADVANZ PHARMA

Sandoz invests $90m to build a biosimilar centre in Slovenia -  Pharmaceutical Technology
Sandoz invests $90m to build a biosimilar centre in Slovenia - Pharmaceutical Technology

Polaris Medical - cel mai mare spital privat de recuperare medicala din  Romania - YouTube
Polaris Medical - cel mai mare spital privat de recuperare medicala din Romania - YouTube

Literature review of international biosimilar medicines update – December  2016 to March 2017 | Australian Government Department of Health and Aged  Care
Literature review of international biosimilar medicines update – December 2016 to March 2017 | Australian Government Department of Health and Aged Care

Tocilizumab biosimilar successfully meets primary, secondary endpoints in  Phase I study: Dr Reddy's Labs
Tocilizumab biosimilar successfully meets primary, secondary endpoints in Phase I study: Dr Reddy's Labs

dr reddy: Dr Reddy's completes clinical studies of its proposed rituximab  biosimilar candidate - The Economic Times
dr reddy: Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate - The Economic Times

Biosimilars as Partners in Oncology: Expert Guidance on Understanding and  Incorporating Biosimilar Agents in Real-World Care
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care

Sandoz Biosimilar Technical Development Centre, Slovenia
Sandoz Biosimilar Technical Development Centre, Slovenia

Switchback BioSim Innovations is excited to transition into our new space  with expanded lab space, new project development labs, and a larger team!  We... | By Switchback Medical | Facebook
Switchback BioSim Innovations is excited to transition into our new space with expanded lab space, new project development labs, and a larger team! We... | By Switchback Medical | Facebook

Samsung Biologics inks biosimilar manufacturing deal with Pfizer
Samsung Biologics inks biosimilar manufacturing deal with Pfizer

BioScript Solutions | What is a biosimilar?
BioScript Solutions | What is a biosimilar?

US FDA accepts Biocon's cancer drug application for review - The Economic  Times
US FDA accepts Biocon's cancer drug application for review - The Economic Times

Biosimilar Testing Services | Testing & Comparability
Biosimilar Testing Services | Testing & Comparability

Expert: generation of biobetters could push out biosimilar development
Expert: generation of biobetters could push out biosimilar development

Policlinica Carit-San Medical - recenzii, fotografii, număr de telefon și  adresă - Centre medicale din Târgu Mureș - Nicelocal.ro
Policlinica Carit-San Medical - recenzii, fotografii, număr de telefon și adresă - Centre medicale din Târgu Mureș - Nicelocal.ro

Guide on Biosimilar Medicines – uemo
Guide on Biosimilar Medicines – uemo

Mylan and Biocon Herceptin biosimilar delayed by FDA for 3 months | Fierce  Pharma
Mylan and Biocon Herceptin biosimilar delayed by FDA for 3 months | Fierce Pharma

Preclinical Clinical Study Centre
Preclinical Clinical Study Centre

Foundation hosts event to launch report on generic & biosimilar medicine  manufacturers | Access to Medicine Foundation
Foundation hosts event to launch report on generic & biosimilar medicine manufacturers | Access to Medicine Foundation